This information was published on 2025-08-06T13:30:59 for IP Right Filed Published.
| Field | Value |
| (210) | 2574236 |
| (220) |
06 Aug 2025
|
| (300) |
US, 20 Feb 2025, 99048597
|
| (511) (510) |
Class 5
Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use in inflammation, immunology, rheumatology, neurology, gastroenterology, dermatology, and hematology; Therapeutic agents, namely, monoclonal antibodies for inhibiting the production and proliferation of autoantibodies, cytokine secretion, and other inflammatory proteins, and antigen uptake; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing autoimmune diseases, inflammatory diseases, immunoglobulin G4-related disease (IgG4-RD), multiple sclerosis, lupus, autoimmune hemolytic anemia, rheumatoid arthritis, and diseases, disorders, and conditions of the immune system. |
| (540) | OBCEYO |
| (550) | Word |
| (730) |
Zenas BioPharma, Inc.
|
| (750) |
Duncan Cotterill Lawyers
|
Find out more about publications on the About page.